Prof. Chaim Gilon is an Active Emeritus Professor of Chemistry at the Hebrew University of Jerusalem, a pioneer in peptide drug development and signal transduction therapy. He holds a Ph.D. in Organic Chemistry and completed postdoctoral research in peptide and brain chemistry at UC San Diego and the Salk Institute with Nobel Laureate Prof. Roger Guillemin. He has authored over 300 scientific publications, holds 45+ patents, and has mentored over 50 Ph.D. and postdoctoral students. He is the inventor and co-founder of Peptor Ltd, former head of the Department of Pharmaceutical Engineering at Azrieli College and currently serves as Director of Peptide Technologies at Starget Pharma. He has advised major pharmaceutical companies, including Teva.
